Oncolytic Virus Testing Services

Oncolytic viruses are one of many therapies under development to combat cancer.  The oncolytic virus is engineered for tumor selectivity, infects cancers cells and destroys them by oncolysis, and stimulates a host anti-tumor immune system response.

With BSL2 facilities and state-of-the-art instrumentation, Eurofins BioPharma Product Testing network of laboratories has vast experience supporting oncolytic virus therapy from early clinical through process validation, product optimization, and marketed release.

Eurofins BioPharma Product Testing provides comprehensive cGMP testing including full method development and validation of viral assays, viral titer, transgene expression, genome quantitation, oncolytic potency assays, and protein aggregation.  Additional details on our services are provided in the links below:

• Viral Safety Testing
• Potency Testing
• Characterization of Biopharma Products
• Sterile Product Testing
• Mycoplasma
• Rapid Mycoplasma
• Residuals Testing
• DNA Sizing and Barcoding
• NexGen Sequencing
• Genetic Stability
• Viral Clearance
• Raw Materials for Biologics
• Trace Metals
• Stability Testing

Our experienced project management and technical teams serve as your single-source solution for all of your testing needs and our secure 24/7 online data portal, LabAccess.com, provides timely access to your test results.